United States Biologics and Biosimilars Industry 2016 Market Research Report

Published Date : 2016-02-16

Published By : QY Research Reports

Category : Pharma & Healthcare

No. of Pages : 131

The United States Biologics and Biosimilars Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biologics and Biosimilars industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologics and Biosimilars market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biologics and Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 151 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents



1 Industry Overview

1.1 Definition and Specifications of Biologics and Biosimilars

1.2 Classification of Biologics and Biosimilars

1.3 Applications of Biologics and Biosimilars

1.4 Industry Chain Structure of Biologics and Biosimilars

1.5 Industry Overview of Biologics and Biosimilars

1.6 Industry Policy Analysis of Biologics and Biosimilars

1.7 Industry News Analysis of Biologics and Biosimilars



2 Manufacturing Cost Structure Analysis of Biologics and Biosimilars

2.1 Bill of Materials (BOM) of Biologics and Biosimilars

2.2 BOM Price Analysis of Biologics and Biosimilars

2.3 Labor Cost Analysis of Biologics and Biosimilars

2.4 Depreciation Cost Analysis of Biologics and Biosimilars

2.5 Manufacturing Cost Structure Analysis of Biologics and Biosimilars

2.6 Manufacturing Process Analysis of Biologics and Biosimilars

2.7 United States Price, Cost and Gross of Biologics and Biosimilars 2011-2016



3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Biologics and Biosimilars Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Biologics and Biosimilars Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Biologics and Biosimilars Key Manufacturers in 2015



4 Production Analysis of Biologics and Biosimilars by Regions, Type, and Applications

4.1 United States Production of Biologics and Biosimilars by Regions 2011-2016

4.2 United States Production of Biologics and Biosimilars by Type 2011-2016

4.3 United States Sales of Biologics and Biosimilars by Applications 2011-2016

4.4 Price Analysis of United States Biologics and Biosimilars Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biologics and Biosimilars 2011-2016



5 Consumption Volume and Consumption Value Analysis of Biologics and Biosimilars by Regions

5.1 United States Consumption Volume of Biologics and Biosimilars by Regions 2011-2016

5.2 United States Consumption Value of Biologics and Biosimilars by Regions 2011-2016

5.3 United States Consumption Price Analysis of Biologics and Biosimilars by Regions 2011-2016



6 Analysis of Biologics and Biosimilars Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Biologics and Biosimilars 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Biologics and Biosimilars 2014-2015

6.3 Sales Overview of Biologics and Biosimilars 2011-2016

6.4 Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016

6.5 Import, Export and Consumption of Biologics and Biosimilars 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Biologics and Biosimilars 2011-2016



7 Analysis of Biologics and Biosimilars Industry Key Manufacturers

7.1 Roche

7.1.1 Company Profile

7.1.2 Product Picture and Specification

7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.1.4 Roche SWOT Analysis



7.2 Amgen

7.2.1 Company Profile

7.2.2 Product Picture and Specification

7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.2.4 Amgen SWOT Analysis



7.3 AbbVie

7.3.1 Company Profile

7.3.2 Product Picture and Specification

7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.3.4 AbbVie SWOT Analysis



7.4 Sanofi-Aventis

7.4.1 Company Profile

7.4.2 Product Picture and Specification

7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.4.4 Sanofi-Aventis SWOT Analysis



7.5 Johnson & Johnson

7.5.1 Company Profile

7.5.2 Product Picture and Specification

7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.5.4 Johnson & Johnson SWOT Analysis



7.6 Pfizer

7.6.1 Company Profile

7.6.2 Product Picture and Specification

7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.6.4 Pfizer SWOT Analysis



7.7 Novo Nordisk

7.7.1 Company Profile

7.7.2 Product Picture and Specification

7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.7.4 Novo Nordisk SWOT Analysis



7.8 Eli Lilly

7.8.1 Company Profile

7.8.2 Product Picture and Specification

7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.8.4 Eli Lilly SWOT Analysis



7.9 Novartis

7.9.1 Company Profile

7.9.2 Product Picture and Specification

7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.9.4 Novartis SWOT Analysis



7.10 Merck

7.10.1 Company Profile

7.10.2 Product Picture and Specification

7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.10.4 Merck SWOT Analysis



7.11 3sbio

7.11.1 Company Profile

7.11.2 Product Picture and Specification

7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.11.4 3sbio SWOT Analysis



7.12 Changchun High Tech

7.12.1 Company Profile

7.12.2 Product Picture and Specification

7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.12.4 Changchun High Tech SWOT Analysis



7.13 CP Guojian Pharmacy

7.13.1 Company Profile

7.13.2 Product Picture and Specification

7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.13.4 CP Guojian Pharmacy SWOT Analysis



7.14 Biotech Pharma

7.14.1 Company Profile

7.14.2 Product Picture and Specification

7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.14.4 Biotech Pharma SWOT Analysis



7.15 Gelgen Biopharma

7.15.1 Company Profile

7.15.2 Product Picture and Specification

7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.15.4 Gelgen Biopharma SWOT Analysis



7.16 Innovent

7.16.1 Company Profile

7.16.2 Product Picture and Specification

7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.16.4 Innovent SWOT Analysis



7.17 Tong Hua Dong Bao Group

7.17.1 Company Profile

7.17.2 Product Picture and Specification

7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.17.4 Tong Hua Dong Bao Group SWOT Analysis



7.18 Ganlee

7.18.1 Company Profile

7.18.2 Product Picture and Specification

7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.18.4 Ganlee SWOT Analysis



7.19 United Laboratories

7.19.1 Company Profile

7.19.2 Product Picture and Specification

7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.19.4 United Laboratories SWOT Analysis



7.20 Teva Pharmaceutical

7.20.1 Company Profile

7.20.2 Product Picture and Specification

7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.20.4 Teva Pharmaceutical SWOT Analysis



7.21 MYLAN

7.21.1 Company Profile

7.21.2 Product Picture and Specification

7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.21.4 MYLAN SWOT Analysis



8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Biologics and Biosimilars Product Types

8.5 Market Share Analysis of Different Biologics and Biosimilars Price Levels

8.6 Gross Margin Analysis of Different Biologics and Biosimilars Applications



9 Marketing Trader or Distributor Analysis of Biologics and Biosimilars

9.1 Marketing Channels Status of Biologics and Biosimilars

9.2 Traders or Distributors of Biologics and Biosimilars with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biologics and Biosimilars

9.4 United States Import, Export and Trade Analysis of Biologics and Biosimilars



10 Development Trend of Biologics and Biosimilars Industry 2016-2021

10.1 Capacity and Production Overview of Biologics and Biosimilars 2016-2021

10.2 Production Market Share by Product Types of Biologics and Biosimilars 2016-2021

10.3 Sales and Sales Revenue Overview of Biologics and Biosimilars 2016-2021

10.4 United States Sales of Biologics and Biosimilars by Applications 2016-2021

10.5 Import, Export and Consumption of Biologics and Biosimilars 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Biologics and Biosimilars 2016-2021



11 Industry Chain Suppliers of Biologics and Biosimilars with Contact Information

11.1 Major Raw Materials Suppliers of Biologics and Biosimilars with Contact Information

11.2 Manufacturing Equipment Suppliers of Biologics and Biosimilars with Contact Information

11.3 Major Players of Biologics and Biosimilars with Contact Information

11.4 Key Consumers of Biologics and Biosimilars with Contact Information

11.5 Supply Chain Relationship Analysis of Biologics and Biosimilars



12 New Project Investment Feasibility Analysis of Biologics and Biosimilars

12.1 New Project SWOT Analysis of Biologics and Biosimilars

12.2 New Project Investment Feasibility Analysis of Biologics and Biosimilars



13 Conclusion of the United States Biologics and Biosimilars Industry 2016 Market Research Report






List of Tables and Figures



Figure Picture of Biologics and Biosimilars

Table Product Specifications of Biologics and Biosimilars

Table Classification of Biologics and Biosimilars

Figure United States Sales Market Share of Biologics and Biosimilars by Product Types in 2015

Table Applications of Biologics and Biosimilars

Figure United States Sales Market Share of Biologics and Biosimilars by Applications in 2015

Figure Industry Chain Structure of Biologics and Biosimilars

Table United States Industry Overview of Biologics and Biosimilars

Table Industry Policy of Biologics and Biosimilars

Table Industry News List of Biologics and Biosimilars

Table Bill of Materials (BOM) of Biologics and Biosimilars

Table Bill of Materials (BOM) Price of Biologics and Biosimilars

Table Labor Cost of Biologics and Biosimilars

Table Depreciation Cost of Biologics and Biosimilars

Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2015

Figure Manufacturing Process Analysis of Biologics and Biosimilars

Table United States Price Analysis of Biologics and Biosimilars 2011-2016 (USD/Unit)

Table United States Cost Analysis of Biologics and Biosimilars 2011-2016 (USD/Unit)

Table United States Gross Analysis of Biologics and Biosimilars 2011-2016

Table Capacity (K Units) and Commercial Production Date of United States Biologics and Biosimilars Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Biologics and Biosimilars Manufacturers in 2015

Table R&D Status and Technology Source of United States Biologics and Biosimilars Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Biologics and Biosimilars Key Manufacturers in 2015

Table United States Production of Biologics and Biosimilars by Regions 2011-2016 (K Units)

Table United States Production Market Share of Biologics and Biosimilars by Regions 2011-2016

Figure United States Production Market Share of Biologics and Biosimilars by Regions in 2014

Figure United States Production Market Share of Biologics and Biosimilars by Regions in 2015

Table United States Production of Biologics and Biosimilars by Types in 2011-2016 (K Units)

Table United States Production Market Share of Biologics and Biosimilars by Type in 2011-2016

Figure United States Production Market Share of Biologics and Biosimilars by Type in 2014

Figure United States Production Market Share of Biologics and Biosimilars by Type in 2015

Table United States Sales of Biologics and Biosimilars by Applications 2011-2016 (K Units)

Table United States Production Market Share of Biologics and Biosimilars by Applications 2011-2016

Figure United States Production Market Share of Biologics and Biosimilars by Applications in 2014

Figure United States Production Market Share of Biologics and Biosimilars by Applications in 2015

Table Price Comparison of United States Biologics and Biosimilars Key Manufacturers in 2015 (USD/Unit)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Biologics and Biosimilars 2011-2016

Table United States Consumption Volume of Biologics and Biosimilars by Regions 2011-2016 (K Units)

Table United States Consumption Volume Market Share of Biologics and Biosimilars by Regions 2011-2016

Figure United States Consumption Volume Market Share of Biologics and Biosimilars by Regions in 2014

Figure United States Consumption Volume Market Share of Biologics and Biosimilars by Regions in 2015

Table United States Consumption Value of Biologics and Biosimilars by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Biologics and Biosimilars by Regions 2011-2016

Figure United States Consumption Value Market Share of Biologics and Biosimilars by Regions in 2014

Figure United States Consumption Value Market Share of Biologics and Biosimilars by Regions in 2015

Table Consumption Price of Biologics and Biosimilars by Regions 2011-2016 (USD/Unit)

Table United States and Major Manufacturers Capacity of Biologics and Biosimilars 2011-2016 (K Units)

Table United States Capacity Market Share of Major Biologics and Biosimilars Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Biologics and Biosimilars 2011-2016 (K Units)

Table United States Production Market Share of Major Biologics and Biosimilars Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Biologics and Biosimilars 2011-2016 (K Units)

Table United States Sales Market Share of Major Biologics and Biosimilars Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Biologics and Biosimilars 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Biologics and Biosimilars Manufacturers 2011-2016

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016

Figure United States Capacity Utilization Rate of Biologics and Biosimilars 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016

Figure United States Production Market Share of Major Biologics and Biosimilars Manufacturers in 2014

Figure United States Production Market Share of Major Biologics and Biosimilars Manufacturers in 2015

Figure United States Sales Market Share of Major Biologics and Biosimilars Manufacturers in 2014

Figure United States Sales Market Share of Major Biologics and Biosimilars Manufacturers in 2015

Figure United States Sales (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016

Table United States Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016 (K Units)

Table United States Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)

Table Price of United States Biologics and Biosimilars Major Manufacturers 2011-2016 (USD/Unit)

Table Gross Margin of United States Biologics and Biosimilars Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Biologics and Biosimilars 2011-2016 (M USD)

Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2011-2016

Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Roche

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Roche 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Roche 2011-2016

Table Roche Biologics and Biosimilars SWOT Analysis

Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Amgen

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Amgen 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Amgen 2011-2016

Table Amgen Biologics and Biosimilars SWOT Analysis

Table AbbVie Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of AbbVie

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of AbbVie 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of AbbVie 2011-2016

Table AbbVie Biologics and Biosimilars SWOT Analysis

Table Sanofi-Aventis Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Sanofi-Aventis

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Sanofi-Aventis 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Sanofi-Aventis 2011-2016

Table Sanofi-Aventis Biologics and Biosimilars SWOT Analysis

Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Johnson & Johnson

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Johnson & Johnson 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Johnson & Johnson 2011-2016

Table Johnson & Johnson Biologics and Biosimilars SWOT Analysis

Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Pfizer

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Pfizer 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Pfizer 2011-2016

Table Pfizer Biologics and Biosimilars SWOT Analysis

Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Novo Nordisk

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Novo Nordisk 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Novo Nordisk 2011-2016

Table Novo Nordisk Biologics and Biosimilars SWOT Analysis

Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Eli Lilly

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Eli Lilly 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Eli Lilly 2011-2016

Table Eli Lilly Biologics and Biosimilars SWOT Analysis

Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Novartis

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Novartis 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Novartis 2011-2016

Table Novartis Biologics and Biosimilars SWOT Analysis

Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Merck

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Merck 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Merck 2011-2016

Table Merck Biologics and Biosimilars SWOT Analysis

Table 3sbio Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of 3sbio

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of 3sbio 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of 3sbio 2011-2016

Table 3sbio Biologics and Biosimilars SWOT Analysis

Table Changchun High Tech Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Changchun High Tech

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Changchun High Tech 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Changchun High Tech 2011-2016

Table Changchun High Tech Biologics and Biosimilars SWOT Analysis

Table CP Guojian Pharmacy Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of CP Guojian Pharmacy

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of CP Guojian Pharmacy 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of CP Guojian Pharmacy 2011-2016

Table CP Guojian Pharmacy Biologics and Biosimilars SWOT Analysis

Table Biotech Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Biotech Pharma

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biotech Pharma 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Biotech Pharma 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Biotech Pharma 2011-2016

Table Biotech Pharma Biologics and Biosimilars SWOT Analysis

Table Gelgen Biopharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Gelgen Biopharma

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Gelgen Biopharma 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Gelgen Biopharma 2011-2016

Table Gelgen Biopharma Biologics and Biosimilars SWOT Analysis

Table Innovent Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Innovent

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Innovent 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Innovent 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Innovent 2011-2016

Table Innovent Biologics and Biosimilars SWOT Analysis

Table Tong Hua Dong Bao Group Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Tong Hua Dong Bao Group

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Tong Hua Dong Bao Group 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Tong Hua Dong Bao Group 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Tong Hua Dong Bao Group 2011-2016

Table Tong Hua Dong Bao Group Biologics and Biosimilars SWOT Analysis

Table Ganlee Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Ganlee

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ganlee 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Ganlee 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Ganlee 2011-2016

Table Ganlee Biologics and Biosimilars SWOT Analysis

Table United Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of United Laboratories

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of United Laboratories 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of United Laboratories 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of United Laboratories 2011-2016

Table United Laboratories Biologics and Biosimilars SWOT Analysis

Table Teva Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of Teva Pharmaceutical

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Teva Pharmaceutical 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of Teva Pharmaceutical 2011-2016

Table Teva Pharmaceutical Biologics and Biosimilars SWOT Analysis

Table MYLAN Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biologics and Biosimilars Picture and Specifications of MYLAN

Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of MYLAN 2011-2016

Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of MYLAN 2011-2016

Figure Biologics and Biosimilars Production (K Units) and United States Market Share of MYLAN 2011-2016

Table MYLAN Biologics and Biosimilars SWOT Analysis

Table Biologics and Biosimilars Price by Regions 2011-2016

Table Biologics and Biosimilars Price by Product Types 2011-2016

Table Biologics and Biosimilars Price by Companies 2011-2016

Table Biologics and Biosimilars Gross Margin by Companies 2011-2016

Table Price Comparison of Biologics and Biosimilars by Regions 2011-2016 (USD/Unit)

Table Price of Different Biologics and Biosimilars Product Types (USD/Unit)

Table Market Share of Different Biologics and Biosimilars Price Level

Table Gross Margin of Different Biologics and Biosimilars Applications

Table Marketing Channels Status of Biologics and Biosimilars

Table Traders or Distributors of Biologics and Biosimilars with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Biologics and Biosimilars (USD/Unit) in 2015

Table United States Import, Export, and Trade of Biologics and Biosimilars (K Units)

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Biologics and Biosimilars 2016-2021

Figure United States Capacity Utilization Rate of Biologics and Biosimilars 2016-2021

Table United States Biologics and Biosimilars Production by Type 2016-2021 (K Units)

Table United States Biologics and Biosimilars Production Market Share by Type 2016-2021

Figure United States Production Market Share of Biologics and Biosimilars by Type in 2021

Figure United States Sales (K Units) and Growth Rate of Biologics and Biosimilars 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Biologics and Biosimilars 2016-2021

Figure United States Sales of Biologics and Biosimilars by Applications 2016-2021 (K Units)

Table United States Production Market Share of Biologics and Biosimilars by Applications 2016-2021

Figure United States Production Market Share of Biologics and Biosimilars by Applications in 2021

Table United States Production, Import, Export and Consumption of Biologics and Biosimilars 2016-2021 (K Units)

Table United States Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021

Table Major Raw Materials Suppliers of Biologics and Biosimilars with Contact Information

Table Manufacturing Equipment Suppliers of Biologics and Biosimilars with Contact Information

Table Major Players of Biologics and Biosimilars with Contact Information

Table Key Consumers of Biologics and Biosimilars with Contact Information

Table Supply Chain Relationship Analysis of Biologics and Biosimilars

Table New Project SWOT Analysis of Biologics and Biosimilars

Table New Project Investment Feasibility Analysis of Biologics and Biosimilars

Table Part of Interviewees Record List

Online Payment

Research Assistance
We will be happy to help you find what you need. Please write to us:

E-Addresssales@qyresearchreports.us